Bonesupport Holding AB (publ) (FRA:2B4)

Market Cap	1.13B -43.7%
Revenue (ttm)	101.23M +37.4%
Net Income	13.74M +67.7%
EPS	0.21 +65.6%
Shares Out	n/a
PE Ratio	82.18
Forward PE	42.53
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Average Volume	124
Open	17.18
Previous Close	17.22
Day's Range	17.11 - 17.47
52-Week Range	16.01 - 35.36
Beta	n/a
RSI	50.47
Earnings Date	Feb 24, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 143
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2B4

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.

Financial numbers in SEK